Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001140361-26-037237

Options or other derivatives

  • Director acquired 12,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kottayil George Director 2026-09-17 Grant or award · Stock Option (Right to Buy) +12,200 12,200 D: show line 1 in the form
Loading xslF345X06/form4.xml…